The National Agency for Food and Drug Administration and Control ( NAFDAC ) has approved the production of chloroquine for clinical trials in the search for a cure for COVID19.
Mojisola Adeyeye, the Director-General of the agency, made the announcement on Friday.
The DG said that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial,” Adeyeye added.
You may be interested
Awoniyi’s Goals Came At Crucial Time For Forest —England LegendWebby - May 30, 2023
Legendary England and Liverpool striker Michael Owen has said Taiwo Awoniyi’s late-season goal flurry came at the right time for…
2023 U-20 W/Cup: We Know How To Beat Argentina — BossoWebby - May 30, 2023
Flying Eagles head coach, Ladan Bosso says he has a plan in place to beat Argentina in their Round of…
Barcelona Star Breaks Up With Luiz Enrique’s DaughterWebby - May 30, 2023
Ferran Torres has broken up with Luis Enrique’s daughter Sira Martinez, per Culemania. Sira herself put an end to the…
Leave a Comment